Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice
Cutaneous leishmaniasis is a major health problem in several parts of the world. However, existing drugs have various therapeutic effects on different Leishmania species and also cause many side effects. This study focuses on the use of the aqueous extract of quercetin in producing silver nanopartic...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Advances in Materials Science and Engineering |
| Online Access: | http://dx.doi.org/10.1155/2023/1878170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849737258423287808 |
|---|---|
| author | Azadeh Ebrahimzadeh Mehdi Karamian Farshid Abedi Mohammad Yahya Hanafi-Bojd Mohammd Amin Ghatee Mina Hemmati Effat Alemzadeh |
| author_facet | Azadeh Ebrahimzadeh Mehdi Karamian Farshid Abedi Mohammad Yahya Hanafi-Bojd Mohammd Amin Ghatee Mina Hemmati Effat Alemzadeh |
| author_sort | Azadeh Ebrahimzadeh |
| collection | DOAJ |
| description | Cutaneous leishmaniasis is a major health problem in several parts of the world. However, existing drugs have various therapeutic effects on different Leishmania species and also cause many side effects. This study focuses on the use of the aqueous extract of quercetin in producing silver nanoparticles for the experimental treatment of cutaneous leishmaniasis in laboratory mice. Silver nanoparticles (AgNPs) were synthesized using quercetin and characterized by UV-Vis spectroscopy, DLS, FTIR, and FESEM. We investigated the antileishmanial activity of green synthesized AgNPs in vitro and in vivo. Synthesized AgNPs from quercetin macromolecules showed promising antileishmanial activity at an IC50 of 125 μg/ml against promastigotes in vitro. In the in vivo study, L. major-infected BALB/c mice were treated topically with luteolin/quercetin-capped silver nanoparticle (AgNPQct) ointment for 21 consecutive days. As a result, this ointment reduced the inflammatory response compared to the untreated group (p < 0.05). The size of lesions in the luteolin/AgNPQct group showed a slight increase compared to other groups (p < 0.01). Biogenic silver nanoparticles along with the luteolin macromolecule can be an effective and reliable candidate for the design of antileishmanial drugs in the future. |
| format | Article |
| id | doaj-art-8366ec3d5125440eaed1f2c262777878 |
| institution | DOAJ |
| issn | 1687-8442 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Materials Science and Engineering |
| spelling | doaj-art-8366ec3d5125440eaed1f2c2627778782025-08-20T03:06:58ZengWileyAdvances in Materials Science and Engineering1687-84422023-01-01202310.1155/2023/1878170Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c MiceAzadeh Ebrahimzadeh0Mehdi Karamian1Farshid Abedi2Mohammad Yahya Hanafi-Bojd3Mohammd Amin Ghatee4Mina Hemmati5Effat Alemzadeh6Infectious Diseases Research CenterDepartment of Parasitology and MycologyInfectious Diseases Research CenterCellular and Molecular Research CenterMedical Microbiology DepartmentDepartment of BiochemistryInfectious Diseases Research CenterCutaneous leishmaniasis is a major health problem in several parts of the world. However, existing drugs have various therapeutic effects on different Leishmania species and also cause many side effects. This study focuses on the use of the aqueous extract of quercetin in producing silver nanoparticles for the experimental treatment of cutaneous leishmaniasis in laboratory mice. Silver nanoparticles (AgNPs) were synthesized using quercetin and characterized by UV-Vis spectroscopy, DLS, FTIR, and FESEM. We investigated the antileishmanial activity of green synthesized AgNPs in vitro and in vivo. Synthesized AgNPs from quercetin macromolecules showed promising antileishmanial activity at an IC50 of 125 μg/ml against promastigotes in vitro. In the in vivo study, L. major-infected BALB/c mice were treated topically with luteolin/quercetin-capped silver nanoparticle (AgNPQct) ointment for 21 consecutive days. As a result, this ointment reduced the inflammatory response compared to the untreated group (p < 0.05). The size of lesions in the luteolin/AgNPQct group showed a slight increase compared to other groups (p < 0.01). Biogenic silver nanoparticles along with the luteolin macromolecule can be an effective and reliable candidate for the design of antileishmanial drugs in the future.http://dx.doi.org/10.1155/2023/1878170 |
| spellingShingle | Azadeh Ebrahimzadeh Mehdi Karamian Farshid Abedi Mohammad Yahya Hanafi-Bojd Mohammd Amin Ghatee Mina Hemmati Effat Alemzadeh Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice Advances in Materials Science and Engineering |
| title | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice |
| title_full | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice |
| title_fullStr | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice |
| title_full_unstemmed | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice |
| title_short | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice |
| title_sort | topically applied luteolin quercetin capped silver nanoparticle ointment as antileishmanial composite acceleration wound healing in balb c mice |
| url | http://dx.doi.org/10.1155/2023/1878170 |
| work_keys_str_mv | AT azadehebrahimzadeh topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT mehdikaramian topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT farshidabedi topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT mohammadyahyahanafibojd topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT mohammdaminghatee topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT minahemmati topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice AT effatalemzadeh topicallyappliedluteolinquercetincappedsilvernanoparticleointmentasantileishmanialcompositeaccelerationwoundhealinginbalbcmice |